Free Trial

Clover Health Investments (CLOV) Competitors

Clover Health Investments logo
$2.59 +0.06 (+2.37%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$2.62 +0.04 (+1.35%)
As of 10/3/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLOV vs. ESNT, ACT, OSCR, FG, LMND, HGTY, ALHC, BWIN, BHF, and PLMR

Should you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Essent Group (ESNT), Enact (ACT), Oscar Health (OSCR), F&G Annuities & Life (FG), Lemonade (LMND), Hagerty (HGTY), Alignment Healthcare (ALHC), Baldwin Insurance Group (BWIN), Brighthouse Financial (BHF), and Palomar (PLMR). These companies are all part of the "insurance" industry.

Clover Health Investments vs. Its Competitors

Essent Group (NYSE:ESNT) and Clover Health Investments (NASDAQ:CLOV) are both insurance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, Essent Group had 3 more articles in the media than Clover Health Investments. MarketBeat recorded 4 mentions for Essent Group and 1 mentions for Clover Health Investments. Essent Group's average media sentiment score of 0.75 beat Clover Health Investments' score of 0.00 indicating that Essent Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Essent Group
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

93.0% of Essent Group shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 2.9% of Essent Group shares are owned by insiders. Comparatively, 24.1% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Essent Group has a net margin of 56.36% compared to Clover Health Investments' net margin of -2.68%. Essent Group's return on equity of 12.66% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Essent Group56.36% 12.66% 9.98%
Clover Health Investments -2.68%-12.20%-6.95%

Essent Group presently has a consensus target price of $63.67, suggesting a potential upside of 3.97%. Clover Health Investments has a consensus target price of $4.37, suggesting a potential upside of 68.60%. Given Clover Health Investments' higher possible upside, analysts plainly believe Clover Health Investments is more favorable than Essent Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Essent Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
Clover Health Investments
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Essent Group has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500.

Essent Group has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Essent Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Essent Group$1.24B4.85$729.40M$6.858.94
Clover Health Investments$1.37B0.97-$43.01M-$0.08-32.38

Summary

Essent Group beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLOV vs. The Competition

MetricClover Health InvestmentsMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.33B$2.23B$6.12B$10.58B
Dividend YieldN/AN/A5.65%4.69%
P/E Ratio-32.3839.3386.9626.71
Price / Sales0.9711.78605.88130.98
Price / CashN/A60.2037.9061.31
Price / Book3.8112.0512.556.55
Net Income-$43.01M-$64.84M$3.31B$277.50M
7 Day Performance-19.06%3.27%4.28%2.42%
1 Month Performance-5.82%6.33%6.90%8.63%
1 Year Performance-35.89%34.71%70.54%31.60%

Clover Health Investments Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLOV
Clover Health Investments
2.3254 of 5 stars
$2.59
+2.4%
$4.37
+68.6%
-35.9%$1.33B$1.37B-32.38680
ESNT
Essent Group
4.3661 of 5 stars
$63.77
-1.5%
$63.67
-0.2%
-4.6%$6.28B$1.24B9.31350News Coverage
ACT
Enact
N/A$38.74
-0.9%
$35.00
-9.7%
+1.4%$5.71B$1.20B8.82500
OSCR
Oscar Health
2.6689 of 5 stars
$19.14
+3.9%
$12.07
-36.9%
+7.5%$4.95B$9.18B-23.632,400Positive News
Short Interest ↓
Gap Up
FG
F&G Annuities & Life
4.4204 of 5 stars
$31.54
-1.1%
$44.33
+40.6%
-28.3%$4.25B$5.74B12.721,338Positive News
LMND
Lemonade
3.3102 of 5 stars
$54.37
+5.7%
$41.14
-24.3%
+226.6%$4.02B$526.50M-19.211,235Positive News
Gap Up
HGTY
Hagerty
3.8115 of 5 stars
$11.72
-2.4%
$13.20
+12.6%
+12.6%$4.01B$1.20B58.601,744Analyst Forecast
Insider Trade
ALHC
Alignment Healthcare
2.3712 of 5 stars
$17.45
-0.5%
$18.83
+7.9%
+52.2%$3.46B$3.34B-62.321,679
BWIN
Baldwin Insurance Group
3.4569 of 5 stars
$27.90
-2.5%
$43.67
+56.5%
-44.1%$3.31B$1.39B-96.214,116News Coverage
Positive News
Analyst Downgrade
BHF
Brighthouse Financial
4.3803 of 5 stars
$54.58
-2.1%
$59.67
+9.3%
+16.2%$3.12B$4.72B5.911,400
PLMR
Palomar
4.6787 of 5 stars
$114.49
-0.6%
$165.83
+44.8%
+13.3%$3.07B$553.86M20.12150Analyst Forecast

Related Companies and Tools


This page (NASDAQ:CLOV) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners